Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group.

Publication ,  Journal Article
Kiviniemi, MT; Hay, JL; James, AS; Lipkus, IM; Meissner, HI; Stefanek, M; Studts, JL; Bridges, JF; Close, DR; Erwin, DO; Jones, RM; Kaiser, K ...
Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
November 2009

The decision aid called "Adjuvant Online" (Adjuvant! for short) helps breast cancer patients make treatment decisions by providing numerical estimates of treatment efficacy (e.g., 10-y relapse or survival). Studies exploring how patients' numeracy interacts with the estimates provided by Adjuvant! are lacking. Pooling across 2 studies totaling 105 women with estrogen receptor-positive, early-stage breast cancer, the authors explored patients' treatment expectations, perceived benefit from treatments, and confidence of personal benefit from treatments. Patients who were more numerate were more likely to provide estimates of cancer-free survival that matched the estimates provided by Adjuvant! for each treatment option compared with patients with lower numeracy (odds ratios of 1.6 to 2.4). As estimates of treatment efficacy provided by Adjuvant! increased, so did patients' estimates of cancer-free survival (0.37 > rs > 0.48) and their perceptions of treatment benefit from hormonal therapy (rs = 0.28) and combined therapy (rs = 0.27). These relationships were significantly more pronounced for those with higher numeracy, especially for perceived benefit of combined therapy. RESULTS: suggest that numeracy influences a patient's ability to interpret numerical estimates of treatment efficacy from decision aids such as Adjuvant!.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

DOI

ISSN

1538-7755

Publication Date

November 2009

Volume

18

Issue

11

Start / End Page

3133 / 3137

Related Subject Headings

  • Practice Guidelines as Topic
  • Neoplasms
  • Humans
  • Epidemiology
  • Early Detection of Cancer
  • Decision Making
  • Communication
  • Biomedical Research
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kiviniemi, M. T., Hay, J. L., James, A. S., Lipkus, I. M., Meissner, H. I., Stefanek, M., … Wang, C. (2009). Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 18(11), 3133–3137. https://doi.org/10.1158/1055-9965.EPI-18-11-ASPO
Kiviniemi, M. T., J. L. Hay, A. S. James, I. M. Lipkus, H. I. Meissner, M. Stefanek, J. L. Studts, et al. “Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group.Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 18, no. 11 (November 2009): 3133–37. https://doi.org/10.1158/1055-9965.EPI-18-11-ASPO.
Kiviniemi MT, Hay JL, James AS, Lipkus IM, Meissner HI, Stefanek M, et al. Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2009 Nov;18(11):3133–7.
Kiviniemi, M. T., et al. “Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group.Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, vol. 18, no. 11, Nov. 2009, pp. 3133–37. Manual, doi:10.1158/1055-9965.EPI-18-11-ASPO.
Kiviniemi MT, Hay JL, James AS, Lipkus IM, Meissner HI, Stefanek M, Studts JL, Bridges JF, Close DR, Erwin DO, Jones RM, Kaiser K, Kash KM, Kelly KM, Craddock Lee SJ, Purnell JQ, Siminoff LA, Vadaparampil ST, Wang C. Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2009 Nov;18(11):3133–3137.

Published In

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

DOI

ISSN

1538-7755

Publication Date

November 2009

Volume

18

Issue

11

Start / End Page

3133 / 3137

Related Subject Headings

  • Practice Guidelines as Topic
  • Neoplasms
  • Humans
  • Epidemiology
  • Early Detection of Cancer
  • Decision Making
  • Communication
  • Biomedical Research
  • 42 Health sciences
  • 32 Biomedical and clinical sciences